Initiative

DeepGlint Igniting AI Aspirations amongst Malaysian New Generation

Retrieved on: 
Monday, March 25, 2024
Faculty, Computing, BHD, Environment, Assistant, Initiative, Shanghai Stock Exchange, Education, Information technology, Management, TAR, Student

DeepGlint, a frontrunner in AI, computer vision, and big data analysis, showcased the Group's innovative solutions across various domains, including the metaverse, intelligent sports, and traffic management.

Key Points: 
  • DeepGlint, a frontrunner in AI, computer vision, and big data analysis, showcased the Group's innovative solutions across various domains, including the metaverse, intelligent sports, and traffic management.
  • The event marked a significant step towards strengthening Malaysia's foothold in the global AI landscape, aligning with Malaysia's vision for greater talent exchange with China.
  • In a pivotal move, DeepGlint also announced the cooperation with a Malaysian AI company, DeepCore Sdn.
  • Mr. Zhao Yong, Founder and Chief Executive Officer of DeepGlint said, "We are pleased to see so many talents in Malaysia.

CASSAVA ALERT: Bragar Eagel & Squire, P.C. is Investigating Cassava Sciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 5, 2024
Cassava Sciences, Science, Initiative, Alzheimer's disease, Telephone, Patient, Defendant, City University, Journal, Biomarker, News, Scientific misconduct, Complaint, P.C, Neurobiology of Aging, Cognition, Safety, Data management, FDA, Pharmaceutical industry

Our investigation concerns whether the board of directors of Cassava have breached their fiduciary duties to the company.

Key Points: 
  • Our investigation concerns whether the board of directors of Cassava have breached their fiduciary duties to the company.
  • The Company's lead therapeutic drug candidate is PTI-125 (or "simufilam"), a small molecule drug for the proposed treatment of Alzheimer's disease.
  • However, in response, Cassava denied the allegations in the Citizen Petition and instead touted the effectiveness of simufilam and the efficacy of the Company's research programs.
  • On this news, Cassava's stock price fell $2.68 per share, or 15.28%, to close at $14.86 per share on October 13, 2023.

Nano Dimension Announces Q1/2024 Preliminary Results - “Reshaping Nano” Initiative Improves Cashflow Dramatically

Retrieved on: 
Thursday, April 4, 2024
Initiative, Dimension, 3D printing, Share repurchase

Waltham, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printing solutions, today announced a preview of its financial results on a preliminary basis for the first quarter ended March 31st, 2024.

Key Points: 
  • Nano Dimension reported unaudited approximated consolidated revenues of $13.2 million for Q1/2024, which demonstrates strong sales in what industry peers have often categorized as a challenged macro environment.
  • The positive change reflects Nano Dimension’s Reshaping Nano Initiative (the “Initiative”), which was originally announced in Q4/2023.
  • The dramatic reduction in cash burn during Q1/2024 proves Nano Dimension is on its way to meeting this target.
  • The above information reflects preliminary estimates with respect to certain results of Nano Dimension for the first quarter ended March 31, 2024, based on currently available information.

ICIC and SRI Release Landmark Report on Enhancing Economic Opportunities in Distressed Communities Through Regional Connectivity

Retrieved on: 
Wednesday, April 3, 2024
Knowledge, The Kresge Foundation, Robert Wood Johnson Foundation, Research, Instrument, Greater Austin, Education, Growth, Initiative, Mechanics, Economic development, Policy, Information technology, Senior, Economy, Workforce, Telecommunications, Public sector, SRI, ICIC, Management

Boston, MA, April 03, 2024 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) and SRI today unveiled a groundbreaking report titled " Regional Economic Connectivity: A Strategy to Build Opportunity in Distressed Communities ."

Key Points: 
  • Boston, MA, April 03, 2024 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) and SRI today unveiled a groundbreaking report titled " Regional Economic Connectivity: A Strategy to Build Opportunity in Distressed Communities ."
  • The report aims to bridge the economic divide by fostering connections between distressed communities and the more prosperous parts of their metropolitan areas.
  • "Regional Economic Connectivity" not only identifies the mechanics of economic integration but also provides actionable insights for economic development professionals, policymakers, community leaders, and private and public sector partners.
  • “Through this report, ICIC and SRI offer a novel approach to economic development that prioritizes both growth and equity,” said Howard Wial, Senior Vice President and Director of Research at ICIC.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA

Retrieved on: 
Sunday, March 31, 2024
Cassava Sciences, Prior, Initiative, Science, District court, Patient, City University, Journal, Biomarker, News, Ext, LLP, Cassava, Complaint, Person, Neurobiology of Aging, Cognition, Safety, Pomerantz, Action Replay, Data management, FDA, Court, Pharmaceutical industry

NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA).

Key Points: 
  • NEW YORK, March 31, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA).
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava

Retrieved on: 
Thursday, March 28, 2024
Cassava Sciences, Science, Initiative, Alzheimer's disease, Patient, City University, Journal, Biomarker, News, LLP, Scientific misconduct, Neurobiology of Aging, Cognition, Safety, Advertising, Data management, FDA, Court, Pharmaceutical industry

Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.

Key Points: 
  • Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia.
  • The firm has recovered hundreds of millions of dollars for investors since its founding in 1995.
  • Faruqi & Faruqi, LLP also encourages anyone with information regarding Cassava’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
  • The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( www.faruqilaw.com ).

Two Anglo American mines are first African iron ore operations audited against the IRMA Standard for Responsible Mining

Retrieved on: 
Wednesday, March 27, 2024
Attention, Responsibility, Initiative, Learning, Non-governmental organization, Kumba Iron Ore, Private sector, Social responsibility, Water resources, Biodiversity, Responsible mining, Safety, Public sector, Standard, Self-assessment, Mining, Audit

SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Today the Initiative for Responsible Mining (IRMA) released the audits of Kumba Iron Ore’s Kolomela and Sishen iron ore operations against the IRMA Standard for Responsible Mining.

Key Points: 
  • SEATTLE, March 27, 2024 (GLOBE NEWSWIRE) -- Today the Initiative for Responsible Mining (IRMA) released the audits of Kumba Iron Ore’s Kolomela and Sishen iron ore operations against the IRMA Standard for Responsible Mining.
  • Independent audit firm ERM-CVS assessed both operations at IRMA 75 when measuring their performance against the Standard’s best practice social and environmental criteria.
  • The full audit reports are available on the Kolomela and Sishen audit pages on the IRMA website .
  • “This report demonstrates that mines can point to transparent, independent evaluations of their environmental and social performance,” said Aimee Boulanger, Executive Director of IRMA.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, March 26, 2024
Apoptosis, Patient, AMX0035, Science, New York Community Bank, NYCB, P.C, Initiative, ACL, Scientific misconduct, IBD, Confidentiality, Safety, Injury, Data management, Food, Signature, Cassava Sciences, ALS, Alzheimer's disease, Defendant, Food and Drug Administration, Journal, Amyotrophy, News, Prescription, Amylyx Pharmaceuticals, Dentist, FDA, City University, Biomarker, Dermatology, Complaint, Investor's Business Daily, Neurobiology of Aging, Cognition, Assumption, Category, BBC World Service, Evercore, Cassava, Pharmaceutical industry

The Company's lead therapeutic drug candidate is PTI-125 (or "simufilam"), a small molecule drug for the proposed treatment of Alzheimer's disease.

Key Points: 
  • The Company's lead therapeutic drug candidate is PTI-125 (or "simufilam"), a small molecule drug for the proposed treatment of Alzheimer's disease.
  • However, in response, Cassava denied the allegations in the Citizen Petition and instead touted the effectiveness of simufilam and the efficacy of the Company's research programs.
  • On this news, Cassava's stock price fell $2.68 per share, or 15.28%, to close at $14.86 per share on October 13, 2023.
  • For more information on the InMode class action go to: https://bespc.com/cases/INMD

KIEHL'S SINCE 1851 & ARTIST BENJAMIN VON WONG UNVEIL "SINGLE-USE REFLECTIONS" IN NYC TO DRIVE ENVIRONMENTAL ACTION

Retrieved on: 
Monday, April 8, 2024
Kiehl, Health, Initiative, Beauty, Line, Hope, Sculpture, Skin, Optimism, High Line, Recycling

NEW YORK, April 8, 2024 /PRNewswire/ -- Kiehl's Since 1851 is proud to unveil "Single-Use Reflections," a sculptural installation by renowned artist & activist, Benjamin Von Wong, appearing on the High Line in New York City from April 4-17. Timed with Earth Month, "Single-Use Reflections," invites viewers to pause for a moment of reflection on how both widespread systemic change and small individual lifestyle shifts, such as using refillable products, can evoke hope and positively impact our planet's future.

Key Points: 
  • NEW YORK, April 8, 2024 /PRNewswire/ -- Kiehl's Since 1851 is proud to unveil "Single-Use Reflections," a sculptural installation by renowned artist & activist, Benjamin Von Wong, appearing on the High Line in New York City from April 4-17.
  • For over 170 years, Kiehl's has been committed to the health of skin and the wellbeing of the world.
  • "I am honored to be partnering with Kiehl's to amplify their message around circularity," said Von Wong.
  • Following its display on the High Line, "Single-Use Reflections" will move to a new location as an important reminder to #DontRebuyJustRefill.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming Deadlines – SAVA

Retrieved on: 
Saturday, March 23, 2024
Cassava Sciences, Prior, Initiative, Science, District court, Patient, City University, Journal, Biomarker, News, Ext, LLP, Cassava, Complaint, Person, Neurobiology of Aging, Cognition, Safety, Pomerantz, Action Replay, Data management, FDA, Court, Pharmaceutical industry

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Cassava Sciences, Inc. (“Cassava” or the “Company”) (NASDAQ: SAVA).
  • To discuss this action, contact Danielle Peyton at [email protected] or 646-581-9980 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.